Insulet Corp. (PODD) Price/FCF Ratio: 25.36
Is Insulet Corp.’s Price/FCF ratio high or low?
Insulet Corp.'s Price/FCF ratio of 25.36 is 66% below its 2-year average of 74.52, near the low end of its 2-year range (23.67–196.47).
49.29% below its 12-month average of 50.01.
PODD Price/FCF Ratio Chart
PODD Average Price/FCF Ratio Chart
PODD Current vs Average Price/FCF Ratio Chart
PODD Price/FCF Ratio Metrics
PRICE/FCF RATIO
25.36
PRICE/FCF RATIO AVG TTM
50.01
PRICE/FCF RATIO AVG 3Y
64.81
PRICE/FCF RATIO AVG 5Y
64.81
PRICE/FCF RATIO AVG 10Y
64.81
PRICE/FCF RATIO AVG 15Y
N/A
PRICE/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-49.29%
CURRENT VS 3Y AVG
-60.87%
CURRENT VS 5Y AVG
-60.87%
CURRENT VS 10Y AVG
-60.87%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
PODD Competitors' Price/FCF Ratio
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Insulet Corp. (PODD) | $10.31B | 25.36 | 50.01 | 64.81 | 64.81 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 17.86 | 17.13 | 29.64 | 17.62 |
| Baxter International Inc. (BAX)vs › | $10.38B | 14.50 | 37.98 | 30.90 | 30.20 |
| Charles River Laboratories International, Inc. (CRL)vs › | $9.73B | 25.28 | 16.56 | 22.61 | 28.23 |
| Revvity, Inc. (RVTY)vs › | $11.14B | 22.63 | 21.98 | 204.85 | 127.25 |
| Henry Schein, Inc. (HSIC)vs › | $9.38B | 21.57 | 20.86 | 20.46 | 19.48 |
| Align Technology, Inc. (ALGN)vs › | $12.24B | 17.84 | 19.01 | 30.71 | 40.22 |
| Solventum Corporation (SOLV)vs › | $13.01B | N/A | 116.92 | 65.01 | 65.01 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.57B | 21.14 | 22.37 | 38.49 | 47.48 |
| Oscar Health, Inc. (OSCR)vs › | $7.56B | 3.44 | 4.25 | 6.95 | 8.54 |
Free Cash Flow Valuation
P/FCF Ratio
25.4
FCF Yield
3.94%
Insulet Corp. Price/FCF Ratio Formula & Definition
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Insulet Corp. Price/FCF Ratio FAQ
- What is the Price/FCF ratio for Insulet Corp. (PODD)?
- The Price/FCF ratio for PODD stock is 25.36.
- Is Insulet Corp.'s Price/FCF ratio high or low?
- Insulet Corp.'s Price/FCF ratio of 25.36 is 66% below its 2-year average of 74.52, near the low end of its 2-year range (23.67–196.47).
- What is the TTM average Price/FCF ratio for Insulet Corp. (PODD)?
- The TTM average Price/FCF ratio for PODD stock is 50.01.
- What is the 3Y average Price/FCF ratio for Insulet Corp. (PODD)?
- The 3Y average Price/FCF ratio for PODD stock is 64.81.
- What is the 5Y average Price/FCF ratio for Insulet Corp. (PODD)?
- The 5Y average Price/FCF ratio for PODD stock is 64.81.
- What is the 10Y average Price/FCF ratio for Insulet Corp. (PODD)?
- The 10Y average Price/FCF ratio for PODD stock is 64.81.
Insulet Corp. Price/FCF Ratio History
| DATE | PRICE/FCF RATIO |
|---|---|
| 2026-06-24 | 25.36 |
| 2026-06-23 | 24.51 |
| 2026-06-22 | 23.67 |
| 2026-06-18 | 24.82 |
| 2026-06-17 | 24.44 |
| 2026-06-16 | 25.15 |
| 2026-06-15 | 25.23 |
| 2026-06-12 | 25.50 |
| 2026-06-11 | 25.41 |
| 2026-06-10 | 25.67 |
| 2026-06-09 | 27.18 |
| 2026-06-08 | 25.80 |
| 2026-06-05 | 26.09 |
| 2026-06-04 | 24.94 |
| 2026-06-03 | 24.41 |
| 2026-06-02 | 24.26 |
| 2026-06-01 | 25.23 |
| 2026-05-29 | 24.68 |
| 2026-05-28 | 24.29 |
| 2026-05-27 | 24.87 |
| 2026-05-26 | 26.19 |
| 2026-05-22 | 26.38 |
| 2026-05-21 | 26.72 |
| 2026-05-20 | 26.67 |
| 2026-05-19 | 26.33 |
| 2026-05-18 | 25.97 |
| 2026-05-15 | 25.11 |
| 2026-05-14 | 25.32 |
| 2026-05-13 | 25.35 |
| 2026-05-12 | 26.97 |
| 2026-05-11 | 26.26 |
| 2026-05-08 | 26.26 |
| 2026-05-07 | 27.32 |
| 2026-05-06 | 25.76 |
| 2026-05-05 | 31.34 |
| 2026-05-04 | 32.07 |
| 2026-05-01 | 32.75 |
| 2026-04-30 | 32.21 |
| 2026-04-29 | 29.94 |
| 2026-04-28 | 34.21 |
| 2026-04-27 | 35.23 |
| 2026-04-24 | 35.47 |
| 2026-04-23 | 35.96 |
| 2026-04-22 | 36.23 |
| 2026-04-21 | 35.98 |
| 2026-04-20 | 37.58 |
| 2026-04-17 | 38.12 |
| 2026-04-16 | 37.69 |
| 2026-04-15 | 37.89 |
| 2026-04-14 | 37.70 |
| 2026-04-13 | 37.01 |
| 2026-04-10 | 36.85 |
| 2026-04-09 | 37.31 |
| 2026-04-08 | 38.08 |
| 2026-04-07 | 37.88 |
| 2026-04-06 | 38.07 |
| 2026-04-02 | 38.23 |
| 2026-04-01 | 38.74 |
| 2026-03-31 | 39.26 |
| 2026-03-30 | 38.92 |
| 2026-03-27 | 38.96 |
| 2026-03-26 | 40.81 |
| 2026-03-25 | 40.41 |
| 2026-03-24 | 42.19 |
| 2026-03-23 | 42.49 |
| 2026-03-20 | 42.49 |
| 2026-03-19 | 42.78 |
| 2026-03-18 | 43.08 |
| 2026-03-17 | 43.12 |
| 2026-03-16 | 42.03 |
| 2026-03-13 | 41.13 |
| 2026-03-12 | 44.17 |
| 2026-03-11 | 44.68 |
| 2026-03-10 | 44.57 |
| 2026-03-09 | 44.97 |
| 2026-03-06 | 44.34 |
| 2026-03-05 | 45.08 |
| 2026-03-04 | 45.44 |
| 2026-03-03 | 45.25 |
| 2026-03-02 | 45.92 |
| 2026-02-27 | 46.14 |
| 2026-02-26 | 47.06 |
| 2026-02-25 | 46.42 |
| 2026-02-24 | 45.89 |
| 2026-02-23 | 46.66 |
| 2026-02-20 | 45.26 |
| 2026-02-19 | 46.61 |
| 2026-02-18 | 48.28 |
| 2026-02-17 | 41.33 |
| 2026-02-13 | 40.72 |
| 2026-02-12 | 40.40 |
| 2026-02-11 | 42.08 |
| 2026-02-10 | 42.34 |
| 2026-02-09 | 41.20 |
| 2026-02-06 | 40.59 |
| 2026-02-05 | 40.79 |
| 2026-02-04 | 42.15 |
| 2026-02-03 | 42.14 |
| 2026-02-02 | 43.05 |
| 2026-01-30 | 42.91 |
| 2026-01-29 | 42.80 |
| 2026-01-28 | 43.32 |
| 2026-01-27 | 44.44 |
| 2026-01-26 | 45.52 |
| 2026-01-23 | 45.56 |
| 2026-01-22 | 46.97 |
| 2026-01-21 | 47.81 |
| 2026-01-20 | 47.69 |
| 2026-01-16 | 48.26 |
| 2026-01-15 | 48.06 |
| 2026-01-14 | 47.46 |
| 2026-01-13 | 46.67 |
| 2026-01-12 | 46.73 |
| 2026-01-09 | 48.49 |
| 2026-01-08 | 49.14 |
| 2026-01-07 | 50.19 |
| 2026-01-06 | 49.38 |
| 2026-01-05 | 47.56 |
| 2026-01-02 | 47.46 |
| 2025-12-31 | 47.68 |
| 2025-12-30 | 48.15 |
| 2025-12-29 | 48.21 |
| 2025-12-26 | 48.42 |
| 2025-12-24 | 48.45 |
| 2025-12-23 | 47.90 |
| 2025-12-22 | 48.91 |
| 2025-12-19 | 48.59 |
| 2025-12-18 | 49.13 |
| 2025-12-17 | 48.58 |
| 2025-12-16 | 48.44 |
| 2025-12-15 | 48.90 |
| 2025-12-12 | 49.61 |
| 2025-12-11 | 49.35 |
| 2025-12-10 | 49.52 |
| 2025-12-09 | 49.36 |
| 2025-12-08 | 49.69 |
| 2025-12-05 | 51.08 |
| 2025-12-04 | 53.00 |
| 2025-12-03 | 51.60 |
| 2025-12-02 | 51.84 |
| 2025-12-01 | 52.15 |
| 2025-11-28 | 54.89 |
| 2025-11-26 | 54.82 |
| 2025-11-25 | 55.17 |
| 2025-11-24 | 56.62 |
| 2025-11-21 | 55.56 |
| 2025-11-20 | 52.49 |
| 2025-11-19 | 58.11 |
| 2025-11-18 | 55.94 |
| 2025-11-17 | 55.03 |
| 2025-11-14 | 55.81 |
| 2025-11-13 | 55.81 |
| 2025-11-12 | 56.51 |
| 2025-11-11 | 54.74 |
| 2025-11-10 | 53.74 |
| 2025-11-07 | 53.65 |
| 2025-11-06 | 54.25 |
| 2025-11-05 | 57.20 |
| 2025-11-04 | 58.26 |
| 2025-11-03 | 57.99 |
| 2025-10-31 | 56.94 |
| 2025-10-30 | 56.75 |
| 2025-10-29 | 57.52 |
| 2025-10-28 | 59.01 |
| 2025-10-27 | 59.27 |
| 2025-10-24 | 58.38 |
| 2025-10-23 | 58.85 |
| 2025-10-22 | 59.89 |
| 2025-10-21 | 59.85 |
| 2025-10-20 | 59.46 |
| 2025-10-17 | 57.96 |
| 2025-10-16 | 57.54 |
| 2025-10-15 | 56.84 |
| 2025-10-14 | 57.91 |
| 2025-10-13 | 57.23 |
| 2025-10-10 | 57.22 |
| 2025-10-09 | 58.28 |
| 2025-10-08 | 57.40 |
| 2025-10-07 | 57.02 |
| 2025-10-06 | 56.70 |
| 2025-10-03 | 56.24 |
| 2025-10-02 | 56.80 |
| 2025-10-01 | 55.67 |
| 2025-09-30 | 56.17 |
| 2025-09-29 | 56.51 |
| 2025-09-26 | 57.85 |
| 2025-09-25 | 58.87 |
| 2025-09-24 | 59.48 |
| 2025-09-23 | 59.63 |
| 2025-09-22 | 60.97 |
| 2025-09-19 | 60.19 |
| 2025-09-18 | 60.67 |
| 2025-09-17 | 58.62 |
| 2025-09-16 | 60.42 |
| 2025-09-15 | 61.91 |
| 2025-09-12 | 62.18 |
| 2025-09-11 | 61.48 |
| 2025-09-10 | 61.42 |
| 2025-09-09 | 64.19 |
| 2025-09-08 | 63.59 |
| 2025-09-05 | 63.39 |
| 2025-09-04 | 63.03 |
| 2025-09-03 | 62.50 |
| 2025-09-02 | 62.75 |
| 2025-08-29 | 61.83 |
| 2025-08-28 | 61.42 |
| 2025-08-27 | 60.83 |
| 2025-08-26 | 60.37 |
| 2025-08-25 | 59.85 |
| 2025-08-22 | 60.17 |
| 2025-08-21 | 59.64 |
| 2025-08-20 | 60.58 |
| 2025-08-19 | 59.58 |
| 2025-08-18 | 58.77 |
| 2025-08-15 | 58.45 |
| 2025-08-14 | 57.45 |
| 2025-08-13 | 56.16 |
| 2025-08-12 | 56.33 |
| 2025-08-11 | 55.46 |
| 2025-08-08 | 55.87 |
| 2025-08-07 | 55.22 |
| 2025-08-06 | 73.58 |
| 2025-08-05 | 74.56 |
| 2025-08-04 | 76.36 |
| 2025-08-01 | 75.60 |
| 2025-07-31 | 76.53 |
| 2025-07-30 | 79.14 |
| 2025-07-29 | 77.35 |
| 2025-07-28 | 77.55 |
| 2025-07-25 | 77.01 |
| 2025-07-24 | 76.04 |
| 2025-07-23 | 76.07 |
| 2025-07-22 | 75.77 |
| 2025-07-21 | 74.55 |
| 2025-07-18 | 75.42 |
| 2025-07-17 | 75.21 |
| 2025-07-16 | 76.49 |
| 2025-07-15 | 76.95 |
| 2025-07-14 | 77.48 |
| 2025-07-11 | 76.77 |
| 2025-07-10 | 78.91 |
| 2025-07-09 | 78.93 |
| 2025-07-08 | 78.68 |
| 2025-07-07 | 79.79 |
| 2025-07-03 | 79.88 |
| 2025-07-02 | 80.03 |
| 2025-07-01 | 79.60 |
| 2025-06-30 | 83.37 |
| 2025-06-27 | 83.07 |
| 2025-06-26 | 82.21 |
| 2025-06-25 | 81.26 |
| 2025-06-24 | 82.50 |
| 2025-06-23 | 81.64 |
| 2025-06-20 | 80.44 |
| 2025-06-18 | 80.08 |
| 2025-06-17 | 80.77 |
| 2025-06-16 | 81.35 |
| 2025-06-13 | 80.83 |
| 2025-06-12 | 80.56 |
| 2025-06-11 | 80.20 |
Showing the most recent 260 of 662 data points. The chart above shows the full history.
Related Metrics
About Insulet Corp.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ashley A. McEvoy